24/7 Patient Assistance: 760-405-8205

Uzair Chaudhary, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Uzair Chaudhary graduated from the Aga Khan Medical College and completed his residency program at the Indiana University School of Medicine. Then, he did a fellowship at the UCSF . Dr. Chaudhary is specialized in Hematology and board certified in Hematology and Medical Oncology. He has been in practice for more than 20 years and is affiliated with the Saint Agnes Medical Center, UCSF Medical Center, Fresno Heart and Surgical Hospital, and Community Regional Medical Center. During his career, he has also contributed to several clinical research publications.

  • Education & Training


    Aga Khan Medical College

    Medical School


    Indiana University School of Medicine





  • Board Certifications

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Community Regional Medical Center

    Languages: English/Spanish

    (559) 459-6000

    2823 Fresno St

    Fresno, California 93721

    Read More

    Fresno Heart & Surgical Hospital

    Languages: English/Spanish

    (559) 433-8000

    15 E. Audubon Drive

    Fresno, California 93720

    Read More

    Saint Agnes Medical Center

    Languages: English/Spanish

    (559) 450-3000

    1303 E Herndon Ave

    Fresno, California 93720

    Read More

    UCSF Medical Center

    Languages: English/Spanish

    (415) 353-1037

    505 Parnassus Ave

    San Francisco, California 94143

    Read More
  • Publications & Memberships

    Dr. Uzair Chaudhary has contributed to 3 publications.

    Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or un...

    Esnaola, N. F.,Chaudhary, U. B.,O'Brien, P.,Garrett-Mayer, E.,Camp, E. R.,Thomas, M. B.,Cole, D. J.,Montero, A. J.,Hoffman, B. J.,Romagnuolo, J.,Orwat, K. P.,Marshall,...; Int. J. Radiat. Oncol. Biol. Phys.. 2014 Mar 13.

    See more >>

    Chemotherapeutic and targeted biological agents for metastatic bladder cancer: A comprehensive review.

    Sio, T. T.,Ko, J.,Gudena, V. K.,Verma, N.,Chaudhary, U. B.; Int. J. Urol.. 2014 Jan 25.

    See more >>

    Phase I Trial of Weekly Docetaxel, Total Androgen Blockade, and Image-Guided Intensity-Modulated Radiotherapy for Localized High-Risk Prostate Adenocarcinoma.

    Marshall, D. T.,Ramey, S.,Golshayan, A. R.,E Keane, T.,Kraft, A. S.,Chaudhary, U.; Clin Genitourin Cancer. 2014 Jan 01.

    See more >>